Atlas Brown’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-416
Closed -$216K – 209
2024
Q3
$216K Buy
416
+5
+1% +$2.67K 0.07% 197
2024
Q2
$223K Buy
411
+4
+1% +$2.11K 0.08% 189
2024
Q1
$211K Buy
+407
New +$202K 0.08% 192
2023
Q1
– Sell
-401
Closed -$206K – 178
2022
Q4
$206K Buy
+401
New +$204K 0.1% 166

Other funds holding ELV

Atlas Brown's ELV Position: Q4 2024 in Review

Atlas Brown sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 416 shares — an estimated $216K sold.

Atlas Brown first reported a position in ELV in Q4 2022 and held it in 4 quarters. The position peaked at $223K in Q2 2024. 1,608 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Atlas Brown reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Atlas Brown sold 416 Elevance Health shares in Q4 2024, an estimated $216K.
  • Atlas Brown first reported a position in Elevance Health in Q4 2022 and held it in 4 quarters.
  • Atlas Brown's Elevance Health position peaked at $223K in Q2 2024.
  • 1,608 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Atlas Brown's 13F filing for Q4 2024, filed 10 Jan 2025.